Dr Martin J Tobin discusses health disparities related to pulse oximeter accuracy and the need for improvement to make health care equitable.

Understanding how AI-driven bias affects Black patients and knowing how to advocate for equitable healthcare is essential.

As concern grows over racial bias in common medical tools like pulse oximeters, ... The FDA wants to change that. Jan 6, 2025. Pulse oximeter performance varies by skin pigment.

The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early debut “to modernize how the agency functions.” ...

Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell ...

When Google announced the Pixel Watch 3 last summer, the company promised it would get a life-saving new feature — Loss of ...

The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets. The Food and Drug Administration ...

The FDA may be facing a 4% cut to its overall budget courtesy of the Trump administration, but that hasn’t stopped the agency from unveiling a new generative AI tool a month ahead of schedule.

CDC and FDA: Deaths in listeria outbreak linked to frozen supplement shakes rise to 14 What are symptoms of salmonella? Salmonella can make people ill with diarrhea, fever, and stomach cramps ...

The FDA introduced Elsa, an artificial intelligence (AI) tool intended to enhance efficiency in clinical reviews and scientific evaluations. News All News Press Releases Product Approvals and Launches ...

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.